The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
From what I can see, GSA reduced their short on Avacta on the 16 April to below 0.5 % , which is the level below what is disclosed, so could have gone all together.
Bein
I can agree with most of that, it’s the childish nature of some people, that occasionally I get very bored with. I have little enough time as it is. Probably a little unfair to children, they usually behave better especially with adults.
To be fair, PL just has a short temper which unleashes at times.
Binned
It’s your obsession with the CEO that is your problem. Onwards and upward!
Not
Why don’t you just accept the situation as it is now, and wait until later when you may have a chance to communicate your displeasure to the CEO and the BOD. We have all heard loud and clear your views and PL’s.
I would have thought you would have sold by now, but apparently not. Get over it and stop behaving like a petulant child. It’s not good for your health, or anybody else’s.
Let’s get forward to a more constructive narrative on the LSE site.
I had a call from a guy at Turner Pope who asked it all had gone well with my registration for the Webinar next Wednesday. I had a short chat with him, and one of the things that emerged was that the embargo on any talk
of anything related to the share raise would be in place until later in April. So no information on that issue at the Webnar. All to do with USA rules, though I did question why as Avacta is an UK AIM share. Still applies
apparently.
Anyone else had a call?
Rab
I think we are on the same page.. Just have to hope the FUD’s disappear soon, it generally ruins the Isa chat board when they are here. I have boxed most of them but still they monopolise the chat with their inane comments.
All you fudsters, that are not invested, it’s a big week for your employers, I suppose , the shorters may have to close their positions before the conference, big risk if they don’t. Perhaps
You should warn TW. Still plenty of time for you to make some more peanuts this next week.
Hopefully you will just Ffff************Kkkk off then.
JWB
Why are you here, what on earth is the point of your posts? Please go, obviously not invested so why do it? You cannot be short on this stock , unless of course have very few grey cells.
Binned!!
Idiot, nobody wins.
What's up with the share price, closed yesterday at 106.4, now 106 and apparently 3.40 up.!!!
It should be up but MM's do not allow it.!!
Could it be something to do with patents being applied for?
T
I take it that you are very risk intolerant. It must be all those questions you ask Google. Every question throws up more questions. You need evidence to back you views up, but you seldom offer any. There is plenty of evidence backing Ava 6000 and Avacta.
Same again wyn. We all know that but no-one would finance them without the backing of shareholders. This company would not be in existence if no shareholders. It is very unlikely that a private biotech could survive on its own in the uk,. USA yes, it has more access to cash.
Brightly
Far too cheap, I would not vote for that!
Don’t take any notice of buys and sells today, not unusual I know. My moderate buy was marked as a sell.
Sorry that should read well under 10bn
Money
It’s well under 6 Ben. £20 is about 6 billion with 300 million shares. A few more shares than that if HCL get all their payment in shares.
I wish it was Wednesday!
Best to be to be a lot clearer and if you are so close try a phone call!